Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer-Reference-Cited by-同舟云学术

Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer

Published:2015-04-08 Issue:4 Volume:10 Page:e0122249
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Ji,Veltri Robert W.,Yuan Zhen,Christudass Christhunesa S.,Mandecki Wlodek

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013

2. Cancer statistics, 2010;A Jemal;CA Cancer J Clin,2010

3. Insignificant prostate cancer and active surveillance: from definition to clinical implications;PJ Bastian;Eur Urol,2009

4. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends;R Etzioni;J Natl Cancer Inst,2002

5. Prostate cancer overdiagnosis and overtreatment;L Klotz;Curr Opin Endocrinol Diabetes Obes,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia;Cancers;2022-09-22

2. Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations;PROTEOMICS;2022-07-14

3. Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype;Cancer Letters;2022-06

4. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia;Cytokine & Growth Factor Reviews;2021-11

5. Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer;Cancers;2021-09-28